BackConstellation Pharmaceuticals Overview

Constellation Pharmaceuticals Net Income

Profitability analysis for CNST.

Quarterly Net Income

-$40.07M
57.49% YoY

As of Mar 2021

Annual Net Income (TTM)

-$140.99M
53.97% YoY

Trailing 12 months ending Mar 2021

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...